These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 24517558)

  • 21. Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus.
    Bakshi J; Hassan S; D'Cruz D; Chan A
    Lupus; 2013 Dec; 22(14):1544-6. PubMed ID: 24014570
    [No Abstract]   [Full Text] [Related]  

  • 22. Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab.
    Tokunaga M; Fujii K; Saito K; Nakayamada S; Tsujimura S; Nawata M; Tanaka Y
    Rheumatology (Oxford); 2005 Feb; 44(2):176-82. PubMed ID: 15494350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab effectiveness in a patient with juvenile systemic lupus erythematosus complicated with acquired Von Willebrand syndrome.
    Jimenez AR; Vallejo ES; Cruz MZ; Cruz AC; Miramontes JV; Jara BS
    Lupus; 2013 Dec; 22(14):1514-7. PubMed ID: 23989733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of refractory acute lupus haemophagocytic syndrome using rituximab: a case report.
    Tomofuji Y; Ishikawa Y; Hattori K; Fujiwara M; Kita Y
    Mod Rheumatol Case Rep; 2020 Jul; 4(2):222-228. PubMed ID: 33087000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unusual acute lupus hemophagocytic syndrome - a test of diagnostic criteria: a case report.
    Wijetunga WMUA; Satarasinghe RL; Dayananda BM; Darshani GK
    J Med Case Rep; 2017 Jul; 11(1):185. PubMed ID: 28683778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single dose of rituximab for pediatric-onset refractory systemic lupus erythematosus.
    Ikeda F; Watanabe S; Aizawa-Yashiro T; Tsuruga K; Ito E; Tanaka H
    Lupus; 2013 Dec; 22(14):1541-3. PubMed ID: 23966305
    [No Abstract]   [Full Text] [Related]  

  • 27. Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002-2004).
    Scheinberg M; Hamerschlak N; Kutner JM; Ribeiro AA; Ferreira E; Goldenberg J; Kiss MH; Chahade WH
    Clin Exp Rheumatol; 2006; 24(1):65-9. PubMed ID: 16539821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclosporin rapidly diminished a severe lupus-associated macrophage association syndrome refractory to pulsed methylprednisolone and intravenous immunoglobulin.
    Takizawa Y; Maruyama J; Setoguchi K
    Scand J Rheumatol; 2009; 38(6):492-4. PubMed ID: 19922027
    [No Abstract]   [Full Text] [Related]  

  • 29. [The long-term efficacy and safety of rituximab combined with cyclophosphamide in treatment of seven patients with refractory and recurrent autoimmune hemolytic anemia].
    Liu H; Xing LM; Wang HQ; Wu YH; Qu W; Liang Y; Wang GJ; Song J; Wang XM; Guan J; Li LJ; Fu R; Shao ZH
    Zhonghua Nei Ke Za Zhi; 2012 Jun; 51(6):456-9. PubMed ID: 22943757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rituximab in pediatric patients with systemic lupus erythematosus].
    Pavón-Sánchez JM; Sánchez-Sánchez LM
    Gac Med Mex; 2013; 149(5):492-6. PubMed ID: 24108334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemophagocytic syndrome as the initial manifestation of systemic lupus erythematosus.
    Egües Dubuc CA; Uriarte Ecenarro M; Meneses Villalba C; Aldasoro Cáceres V; Hernando Rubio I; Belzunegui Otano J
    Reumatol Clin; 2014; 10(5):321-4. PubMed ID: 24316336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, biological and ultrasonographic remission in a patient with musculoskeletal systemic lupus erythematosus with rituximab.
    Torrente-Segarra V; Lisbona-Pérez M; Rotes-Sala D; Castro-Oreiro S; Carbonell-Abelló J
    Lupus; 2009 Mar; 18(3):270-2. PubMed ID: 19213868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus].
    Lehembre S; Macario-Barrel A; Musette P; Carvalho P; Joly P
    Ann Dermatol Venereol; 2006 Jan; 133(1):53-5. PubMed ID: 16495854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rituximab therapy for severe pediatric systemic lupus erythematosus].
    Su GX; Wu FQ; Wang F; Zhou ZX; Huang XL; Lu J
    Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):697-704. PubMed ID: 23158822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Danazol therapy in autoimmune hemolytic anemia associated with systemic lupus erythematosus.
    Chan AC; Sack K
    J Rheumatol; 1991 Feb; 18(2):280-2. PubMed ID: 2023224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe refractory autoimmune hemolytic anemia with five-year complete hematologic response to third course of treatment with rituximab: a case report.
    Abadie K; Hege KM
    J Med Case Rep; 2014 Jun; 8():175. PubMed ID: 24889270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.
    Jovancevic B; Lindholm C; Pullerits R
    Lupus; 2013 Jun; 22(7):664-74. PubMed ID: 23612795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.
    Ramos-Casals M; García-Hernández FJ; de Ramón E; Callejas JL; Martínez-Berriotxoa A; Pallarés L; Caminal-Montero L; Selva-O'Callaghan A; Oristrell J; Hidalgo C; Pérez-Alvarez R; Micó ML; Medrano F; Gómez de la Torre R; Díaz-Lagares C; Camps M; Ortego N; Sánchez-Román J;
    Clin Exp Rheumatol; 2010; 28(4):468-76. PubMed ID: 20525449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of systemic lupus erythematosus-related refractory autoimmune hemolytic anemia with ofatumumab.
    Poulet A; Jarrot PA; Mazodier K; Jean R; Kaplanski G
    Lupus; 2019 Dec; 28(14):1735-1736. PubMed ID: 31610746
    [No Abstract]   [Full Text] [Related]  

  • 40. Intractable Hemophagocytic Syndrome Associated with Systemic Lupus Erythematosus Resistant to Corticosteroids and Intravenous Cyclophosphamide That Was Successfully Treated with Cyclosporine A.
    Toko H; Tsuboi H; Umeda N; Honda F; Ohyama A; Takahashi H; Abe S; Yokosawa M; Asashima H; Hagiwara S; Hirota T; Kondo Y; Matsumoto I; Sumida T
    Intern Med; 2018 Sep; 57(18):2747-2752. PubMed ID: 29780126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.